Author Correction: Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
Enregistré dans:
Auteurs principaux: | Xueju Zhang, Weiwei Liu, Jie Zan, Chuanbin Wu, Wen Tan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3c47bd988c034cefb0f5a4c5418d59dc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
par: Nikisha Carty, et autres
Publié: (2013) -
Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice.
par: Neel R Nabar, et autres
Publié: (2012) -
Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
par: Xiaomei Lu, et autres
Publié: (2019) -
The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
par: Dmitrii Smirnov, et autres
Publié: (2021) -
Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
par: Long-Long Cao, et autres
Publié: (2021)